Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Comparison of Toxicity for Methyl Iodide and Methyl Bromide Prepared by Susan E. Kegley, Ph.D., Consulting Scientist, Pesticide Action Network Methyl iodide (iodomethane) is currently being introduced in some parts of the U.S. as a replacement for methyl iodide. There are some inaccuracies being circulated about the relative toxicity of methyl iodide vs methyl bromide. This document summarizes the known toxicity information for methyl bromide and methyl iodide and cites the sources of the data. Quick Summary: • Methyl iodide is about four times more neurotoxic than methyl bromide. This means that the amount of methyl iodide required to cause noticeable neurotoxicity in experimental animals is four times lower than the amount of methyl bromide required for the same effect. • Methyl iodide is 1.1-3.5 times more acutely toxic than methyl bromide. This means that the amount of methyl iodide needed to cause death in 50% of exposed animals is 1.1 to 3.5 times less than the amount of methyl bromide, for the same effect. The variation is related to the species tested—rats or mice—and the length of time the animals were exposed. • The OSHA-allowed exposure level for methyl iodide is four times lower than that for methyl bromide. The Occupational Safety and Health Administration (OSHA) sets Permissable Exposure Limits (PELs) for different chemicals, and has set the PEL for methyl iodide four times lower than that for methyl bromide. • Methyl iodide is a carcinogen; methyl bromide is not. Methyl iodide is on the California Proposition 65 list of carcinogens, and methyl bromide is not. Methyl iodide causes thyroid tumors. • Methyl iodide causes developmental toxicity at doses four times lower than methyl bromide. Methyl iodide causes “fetal losses” (miscarriages) by interfering with the thyroid hormone levels during pregnancy. Methyl bromide causes birth defects and is on the California Prop 65 list of developmental toxicants, but these effects are observed at doses higher than those for methyl iodide toxicity. Methyl iodide has not yet been reviewed for inclusion on the Prop 65 list for developmental toxicity. • Methyl iodide is toxic to the thyroid gland. Because of the iodine in methyl iodide, this chemical targets the thyroid gland. The developmental toxicity is related to methyl iodide’s interference with thyroid hormone levels that are essential for successful fetal development. Methyl bromide does not have the same type of effect on the fetus, although it does have other effects. • For short-term and long-term exposures, methyl bromide is up to twice as toxic as methyl iodide. The endpoints here are salivary gland metaplasia (a change in cell type that is an adaptive response to a stressor like chemical exposure) for methyl iodide and lesions of the lining of the nose for methyl bromide. Tables 1 and 2 on the following pages provide more detailed information and the sources of the information. Table 1: Comparison of Acute Toxicity for Methyl Iodide and Methyl Bromide Study Description Inhalation Acute Neurotoxicity – Rats Six-hour exposure (EPA guideline 870.6200) Methyl iodide Methyl bromide Ratio, MeBr/MeIk NOAEL = 27 ppm LOAEL = 93 ppm NOAEL = 100 ppm LOAEL = 350 ppm NOAEL, 3.70 LOAEL, 3.76 Acute Inhalation – Rat 4-hour LC50 exposure (EPA guideline 870.1300) 691 ppm* 776 ppm 1.12 LC50 Mouse inhalation 1-hour exposure 865 ppmc 1,200 ppmd 1.39 LC50 Rat inhalatione 4-hour exposure 225 ppm 780 ppm g 3.47 OSHA PELh 8-hour time-weighted avg. 5 ppm 20 ppm 4.00 LC50 Rat inhalationi 30 minute exposure 1,750 ppm 2,800 ppm 1.60 LD50 Rat orale 76 mg/kg (0.53 mmol/kg) 214 mg/kg (2.25 mmol/kg) 2.82 (on a per gram basis) 4.24 (on a per molecule basis) LC50 = concentration that is lethal to 50% of the test animals; NOAEL = No Observed Adverse Effect Level, the dose at which no adverse effects were observed; LOAEL = Lowest Observed Adverse Effect Level, the lowest dose at which adverse effects were still observed; ppm = parts per million; mg/kg = milligrams of pesticide per kilogram of body weight; mmol/kg = millimoles of pesticide per kilogram of body weight. * There appears to be a mistake in the data table of Appendix B of the Iodomethane Preliminary Risk Assessment, U.S. EPA, January 2006, so it is not clear what the 4-h LC50 should be for iodomethane. At another place in the risk assessment, the value is given as 4 mg/L (691 ppm). a Iodomethane Preliminary Risk Assessment, Appendix B: Toxicity Profile, U.S. EPA, January 2006. b Methyl Bromide Preliminary Risk Assessment, Appendix A: Toxicity Profile, U.S. EPA, July 2005. c G.D.Clayton, F.E. Clayton, (eds.) Patty’s Industrial Hygiene and Toxicology, Volumes 2A-2F, Toxicology. 4th ed., John Wiley & Sons (New York, 1993-1994. d Alexeef GV et al; J Toxicol Environ Health 15 (1): 109-23 (1985). e R.J. Lewis, Sax’s Dangerous Properties of Industrial Materials, 9th ed, Vol. 1-3, Van Nostrand-Reinhold (New York, 1996). f Kato W et al; Indust Health 24 (2): 87-103 (1986). g IPCS, Intox Databank, Canadian Center for Occupational Safety and Health, http://www.intox.org/databank/index.htm. h OSHA Permissable Exposure Limits, 29 CFR 1910.1000, Table Z-1: Limits for Air Contaminants, 2003. i G.N. Bakhishev, Relation between the chemical structure and toxicity of some halolgenated aliphatic hydrocarbons, Fiziol. Akt. Veshchestva 7:35-36 (1975) (Rs), from NIOSH Current Intelligence Bulletin 43: Monohalomethanes, Methyl Chloride, Methyl Bromide and Methyl Iodide, Sept. 1984, http://222.cdc.gov/niosh/84117_43.html. j Because lower LD50 values, NOAELs and LOAELs mean HIGHER toxicity, this ratio gives the factor by which methyl iodide is more toxic than methyl bromide. k This column shows the ratio of the doses required to cause an effect between methyl bromide and methyl iodide. A lower dose means the compound is more toxic, with less exposure required to see an effect. Table 2: Comparison of Other Types of Toxicity for Methyl Iodide and Methyl Bromide Methyl iodide Methyl bromide Comparison MeBr/MeIb NOAEL = 10 ppm LOAEL = 20 ppm NOAEL = 40 ppm LOAEL = 80 ppm NOAEL, 4.0 LOAEL, 4.0 State of CA (Prop 65): Not yet evaluated as a developmental toxicant. State of CA (Prop 65): Listed as a developmental toxicant. Thyroid toxicitya Thyroid toxicity is the primary mechanism of developmental toxicity and carcinogenicity. No thyroid toxicity MeI is a thyroid toxicant; MeBr is not. Short-term non-cancer toxicity via the inhalation a route NOAEL = 5 ppm LOAEL = 20 ppm NOAEL = 5 ppm LOAEL = 10 ppm NOAEL, 1.0 LOAEL, 0.5 Long-term, non-cancer toxicity via the inhalation a route NOAEL = 5 ppm LOAEL = 20 ppm NOAEL = not identified, but < 3 ppm LOAEL = 3 ppm NOAEL < 0.6 LOAEL, 0.15 EPA: Not likely to be carcinogenic to humans at doses that do not disrupt thyroid hormone homeostasis. Likely to be carcinogenic at doses that do disrupt thyroid hormone homeostasis. EPA: Not likely to be a human carcinogen. MeI is listed as a carcinogen by the state of California; MeBr is not. Study Description Developmental toxicity Carcinogenicity a a State of CA (Prop 65): Listed as a carcinogen. International Agency for Research on Cancer: Inadequate evidence for carcinogenicity to humans and limited evidence for carcinogenicity to animals; the overall evaluation of carcinogenicity to humans was "not classifiable" (group 3). State of CA (Prop 65): Evaluated for carcinogenicity, but not listed as a carcinogen. International Agency for Research on Cancer: Inadequate evidence for carcinogenicity to humans and limited evidence for carcinogenicity to animals; the overall evaluation of carcinogenicity to humans was "not classifiable" (group 3). NOAEL = No Observed Adverse Effect Level, the dose at which no adverse effects were observed; LOAEL = Lowest Observed Adverse Effect Level, the lowest dose at which adverse effects were still observed; ppm = parts per million. Data taken from EPA’s risk assessments for methyl iodide (Iodomethane: Revised HED Human Health Risk Assessment Which Incorporates Results of Human Iodine Monitoring, 10/1/2007, http://www.regulations.gov/fdmspublic/component/main?main=DocketDetail&d=EPA-HQ-OPP-2005-0252, Document number EPA-HQ-OPP-2005-0252-0051) and methyl bromide (Methyl Bromide: Phase 5 Health Effects Division (HED) Human Health Risk Assessment For Soil, Greenhouse, and Residential/Structural Uses, April 10, 2007, http://www.regulations.gov/fdmspublic/component/main?main=DocketDetail&d=EPA-HQ-OPP-2005-0123, Document number EPA-HQ-OPP-2005-0123-0285. a b This column shows the ratio of the doses required to cause an effect between methyl bromide and methyl iodide. A lower dose means the compound is more toxic, with less exposure required to see an effect.